Skip to main content
West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
292.13
-10.07 (-3.33%)
Apr 28, 2026, 4:00 PM EDT - Market closed

WST Revenue

West Pharmaceutical Services had revenue of $844.90M in the quarter ending March 31, 2026, with 21.05% growth. This brings the company's revenue in the last twelve months to $3.22B, up 11.23% year-over-year. In the year 2025, West Pharmaceutical Services had annual revenue of $3.07B with 6.25% growth.

Revenue (ttm)
$3.22B
Revenue Growth
+11.23%
P/S Ratio
6.41
Revenue / Employee
$298,241
Employees
10,800
Market Cap
20.64B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.07B180.90M6.25%
Dec 31, 20242.89B-56.60M-1.92%
Dec 31, 20232.95B62.90M2.18%
Dec 31, 20222.89B55.30M1.95%
Dec 31, 20212.83B684.70M31.89%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medline 28.43B
Becton, Dickinson and Company 21.92B
Baxter International 11.24B
Alcon 10.40B
Solventum 8.33B
ResMed 5.40B
The Cooper Companies 4.15B
Align Technology 4.03B
Revenue Rankings

WST News

More News